ODDO BHF Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

ODDO BHF Asset Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-825,000	Closed	-$33.2M	–	260
2026 Q1	$33.2M	Buy	+825,000	New	+$17.8M	1.31%	16

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ODDO BHF Asset Management's APLS Position: Q2 2026 in Review

ODDO BHF Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 825,000 shares — an estimated $33.2M sold.

ODDO BHF Asset Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $33.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

ODDO BHF Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
ODDO BHF Asset Management sold 825,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $33.2M.
ODDO BHF Asset Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
ODDO BHF Asset Management's Apellis Pharmaceuticals position peaked at $33.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on ODDO BHF Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.